These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1817961)

  • 1. Effects of repeated administration of the preferential dopamine autoreceptor antagonist, (+)-AJ76, on locomotor activity and brain DA metabolism in the rat.
    Kullingsjö H; Carlsson A; Svensson K
    Eur J Pharmacol; 1991 Dec; 205(3):241-6. PubMed ID: 1817961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebral infusion of (+)-AJ76 and (+)-UH232: effects on dopamine release and metabolism in vivo.
    Waters N; Hansson L; Löfberg L; Carlsson A
    Eur J Pharmacol; 1994 Jan; 251(2-3):181-90. PubMed ID: 8149975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232.
    Piercey MF; Lum JT; Hoffmann WE; Carlsson A; Ljung E; Svensson K
    Brain Res; 1992 Aug; 588(2):217-22. PubMed ID: 1393576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study).
    Sotnikova TD; Gainetdinov RR; Grekhova TV; Rayevsky KS
    Pharmacol Res; 2001 Mar; 43(3):283-90. PubMed ID: 11401421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the preferential dopamine autoreceptor antagonist (+)-AJ76 in the intracranial self-stimulation paradigm.
    Kling-Petersen T; Svensson K
    Pharmacol Biochem Behav; 1992 Oct; 43(2):495-501. PubMed ID: 1438487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis.
    Gainetdinov RR; Sotnikova TD; Grekhova TV; Rayevsky KS
    Eur J Pharmacol; 1996 Jul; 308(3):261-9. PubMed ID: 8858296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study.
    Waters N; Lagerkvist S; Löfberg L; Piercey M; Carlsson A
    Eur J Pharmacol; 1993 Sep; 242(2):151-63. PubMed ID: 8253112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
    Batool F; Hasnat A; Haleem MA; Haleem DJ
    Acta Pharm; 2010 Jun; 60(2):129-40. PubMed ID: 21134850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats.
    Sershen H; Harsing LG; Hashim A; Lajtha A
    Life Sci; 1992; 51(13):1003-11. PubMed ID: 1522749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of quinpirole on striatal dopamine release and locomotor activity in nicotine-treated mice.
    Tammimäki A; Pietilä K; Raattamaa H; Ahtee L
    Eur J Pharmacol; 2006 Feb; 531(1-3):118-25. PubMed ID: 16442094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased dopamine release by the autoreceptor antagonist (+)-AJ 76 is Ca2(+)-dependent.
    Waters N; Löfberg L; Svensson K; Carlsson A
    Eur J Pharmacol; 1990 Oct; 187(3):425-34. PubMed ID: 2073922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response.
    Hillegaart V; Ahlenius S; Magnusson O; Fowler CJ
    Pharmacol Biochem Behav; 1987 May; 27(1):159-64. PubMed ID: 3615537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic interactions between the NMDA antagonist dizocilpine and the preferential dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 with regard to locomotor stimulation in monoamine-depleted mice.
    Svensson A; Carlsson M; Carlsson A
    J Neural Transm Gen Sect; 1991; 85(1):69-77. PubMed ID: 1867840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats.
    Millan MJ; Seguin L; Gobert A; Cussac D; Brocco M
    Psychopharmacology (Berl); 2004 Jul; 174(3):341-57. PubMed ID: 14985929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
    Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Carlsson A
    J Med Chem; 1987 Apr; 30(4):602-11. PubMed ID: 3560156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity.
    Benwell ME; Balfour DJ
    Br J Pharmacol; 1992 Apr; 105(4):849-56. PubMed ID: 1504716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats.
    Invernizzi R; Morali F; Pozzi L; Samanin R
    Br J Pharmacol; 1990 Aug; 100(4):774-8. PubMed ID: 2207499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
    Nomikos GG; Arborelius L; Höök BB; Hacksell U; Svensson TH
    J Neural Transm (Vienna); 1996; 103(5):541-54. PubMed ID: 8811500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain.
    Antkiewicz-Michaluk L; Karolewicz B; Romańska I; Michaluk J; Bojarski AJ; Vetulani J
    Eur J Pharmacol; 2003 Apr; 466(3):263-9. PubMed ID: 12694809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.